Products

What will AGI do for Apraclonidine or iopidine?

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H10Cl2N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 843CEN85DI, chemically known as 2,6-dichloro-n-(4,5-dihydro-1h-imidazol-2-yl)benzene-1,4-diamine but generally known as apraclonidine, which bears US NIH Compound Identifier 2216. Apraclonidine most often comes in base and hydrochloride forms. European Medicines Agency schedules Apraclonidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05539MIG. The term APRACLONIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules apraclonidine in its Anatomical Therapeutic Chemical (ATC) Classification. APRACLONIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Apraclonidine or iopidine bears US NLM identifiers UMLS ID C0048038 and NCI Concept Code C61640. SMILES: CLC1C(NC2=NCCN2)C(CL)CC(N)C1.